ABEXTIN

Active ingredients

The drug ABEXTIN contains one active pharmaceutical ingredient (API):

UNII 9IY2357JPE - RIVASTIGMINE TARTRATE

Rivastigmine is an acetyl- and butyrylcholinesterase inhibitor of the carbamate type, thought to facilitate cholinergic neurotransmission by slowing the degradation of acetylcholine released by functionally intact cholinergic neurones. Thus, rivastigmine may have an ameliorative effect on cholinergic-mediated cognitive deficits in dementia associated with Alzheimer’s disease and Parkinson’s disease.

Read about Rivastigmine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
Rivastigmine
N Nervous system → N06 Psychoanaleptics → N06D Anti-dementia drugs → N06DA Anticholinesterases
Discover more medicines within N06DA03

Authorization and marketing

This brand name is authorized in the following countries: Turkey

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
TR
İlaç ve Tıbbi Cihaz Kurumu
Identifier(s): 8699536650029